Suppr超能文献

慢性淋巴细胞白血病细胞表达的CCL3趋化因子调控着淋巴结浸润中微环境的组成。

CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates.

作者信息

Hartmann Elena M, Rudelius Martina, Burger Jan A, Rosenwald Andreas

机构信息

a Institute of Pathology , University of Würzburg, Würzburg and Comprehensive Cancer Center (CCC) Mainfranken , Germany and.

b Department of Leukemia , MD Anderson Cancer Center , Houston , Texas , USA.

出版信息

Leuk Lymphoma. 2016;57(3):563-71. doi: 10.3109/10428194.2015.1068308. Epub 2015 Oct 12.

Abstract

Previous experiments demonstrated that survival and proliferation of chronic lymphocytic leukemia (CLL) cells depends upon complex cross-talk between CLL cells and accessory cells in the tissue microenvironment. To further dissect these interactions in situ, we analyzed lymph nodes from 43 different patients infiltrated by CLL cells for expression of the chemokine CCL3, Ki-67, macrophages, and T cell subsets by immunohistochemistry. CCL3 expression was detected in 24 of 43 cases (56%), particularly in prolymphocytes and paraimmunoblasts within the proliferation centers. Significantly higher numbers of CD3+ T cells and CD57+ cells were noticed in CCL3 positive cases. Furthermore, denser infiltration of CLL lymph node tissues by CD57+ cells correlated with higher proliferation rates of the CLL cells. In conclusion, we demonstrate an association of CCL3 expression by CLL cells with increased numbers of CD3+ T cells and CD57+ cells in the lymph node microenvironment, which may promote CLL cell survival and proliferation.

摘要

先前的实验表明,慢性淋巴细胞白血病(CLL)细胞的存活和增殖取决于CLL细胞与组织微环境中辅助细胞之间复杂的相互作用。为了进一步在原位剖析这些相互作用,我们通过免疫组织化学分析了43例不同患者被CLL细胞浸润的淋巴结中趋化因子CCL3、Ki-67、巨噬细胞和T细胞亚群的表达情况。在43例病例中的24例(56%)检测到CCL3表达,尤其在增殖中心的幼淋巴细胞和成淋巴细胞样细胞中。在CCL3阳性病例中,CD3+ T细胞和CD57+细胞的数量显著增多。此外,CD57+细胞对CLL淋巴结组织的浸润越密集,CLL细胞的增殖速率越高。总之,我们证明CLL细胞中CCL3的表达与淋巴结微环境中CD3+ T细胞和CD57+细胞数量的增加有关,这可能促进CLL细胞的存活和增殖。

相似文献

3
CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia.
Acta Haematol. 2023;146(4):277-286. doi: 10.1159/000526397. Epub 2023 Apr 4.
10
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.
Blood. 2011 Feb 3;117(5):1662-9. doi: 10.1182/blood-2010-09-307249. Epub 2010 Nov 29.

引用本文的文献

1
Therapeutic implications of endoplasmic reticulum stress gene CCL3 in cervical squamous cell carcinoma.
Cell Biol Toxicol. 2025 Feb 20;41(1):47. doi: 10.1007/s10565-024-09949-3.
2
MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms.
Sci Rep. 2023 Oct 6;13(1):16839. doi: 10.1038/s41598-023-44174-8.
3
Chronic Lymphocytic Leukemia: Disease Biology.
Acta Haematol. 2024;147(1):8-21. doi: 10.1159/000533610. Epub 2023 Sep 16.
5
In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing.
Cancers (Basel). 2022 Jun 23;14(13):3087. doi: 10.3390/cancers14133087.
6
Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures.
Leukemia. 2022 May;36(5):1324-1335. doi: 10.1038/s41375-022-01519-y. Epub 2022 Feb 11.
7
Leukaemia: a model metastatic disease.
Nat Rev Cancer. 2021 Jul;21(7):461-475. doi: 10.1038/s41568-021-00355-z. Epub 2021 May 5.
9
Targeting Casein Kinase 1 (CK1) in Hematological Cancers.
Int J Mol Sci. 2020 Nov 27;21(23):9026. doi: 10.3390/ijms21239026.
10
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia.
Leukemia. 2021 Jun;35(6):1610-1620. doi: 10.1038/s41375-020-01063-7. Epub 2020 Oct 21.

本文引用的文献

2
Pathophysiology of T follicular helper cells in humans and mice.
Nat Immunol. 2015 Feb;16(2):142-52. doi: 10.1038/ni.3054.
3
Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism.
J Immunol. 2015 Jan 15;194(2):827-35. doi: 10.4049/jimmunol.1401350. Epub 2014 Dec 10.
5
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study.
Lancet Oncol. 2014 Sep;15(10):1090-9. doi: 10.1016/S1470-2045(14)70335-3. Epub 2014 Aug 20.
7
Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.
Cell Rep. 2013 Aug 15;4(3):566-77. doi: 10.1016/j.celrep.2013.07.011. Epub 2013 Aug 8.
8
Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer.
Br J Cancer. 2013 Aug 20;109(4):1013-22. doi: 10.1038/bjc.2013.362. Epub 2013 Jul 18.
9
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.
N Engl J Med. 2013 Jul 4;369(1):32-42. doi: 10.1056/NEJMoa1215637. Epub 2013 Jun 19.
10
Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.
Hematol Oncol Clin North Am. 2013 Apr;27(2):173-206. doi: 10.1016/j.hoc.2013.01.002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验